FindTrial
Sign In

Evaluating the incidence, risk factors and clinical outcome of new origin kidney disease in Liver Transplant patients

Acute Kidney Injury post Live Donor Liver Transplantation (LDLT): Incidence, Risk factors and Clinical outcomes. - NIL

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/02/063001
Enrollment
3000
Registered
2024-02-21
Start date
Unknown
Completion date
Unknown
Last updated
2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N179- Acute kidney failure, unspecified Health Condition 2: N179- Acute kidney failure, unspecified

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Adult patient (=18 years) All adult patients undergoing Live Donor Liver Transplantation (LDLT)

Exclusion criteria

Exclusion criteria: Patients =18 years Patients requiring renal replacement therapy prior to LDLT Patients who had other organ transplantation alongwith LDLT

Design outcomes

Primary

MeasureTime frame
Incidence of AKI in LDLT patients till discharge or death Evaluation of risk factors responsible for AKI LDLT till discharge or death Timepoint: Incidence of AKI in LDLT patients till discharge or death Evaluation of risk factors responsible for AKI LDLT till discharge or death—

Secondary

MeasureTime frame
Effect of AKI on the length of ICU stay Effect of AKI on the length of total hospital stay Effect of AKI on one month mortality Effect of AKI on Vasopressor days Effect of AKI on Mechanical Ventilation days Timepoint: Till discharge or death—

Countries

India

Contacts

Public ContactDr Pooja Tyagi

Medanta, The Medicity, Gurgaon

poojatyagi1919@gmail.com122001

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026